Journal ArticleOPEN ACCESS

The Finding of N-Nitrosodimethylamine in Common Medicines

  • Adamson R
  • Chabner B
The Oncologist (2020) 25(6) 460-462
DOI: 10.1634/theoncologist.2020-0142
19Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The FDA has ordered the withdrawal of all ranitidine products from the marketplace based on recent findings of increased and unacceptable levels of N-nitrosodimethylamine (NDMA). This commentary reviews the sources and properties of NDMA, assesses the dangers it poses, and suggests measures to mitigate contamination.

Cite

CITATION STYLE

APA

Adamson, R. H., & Chabner, B. A. (2020). The Finding of N-Nitrosodimethylamine in Common Medicines. The Oncologist, 25(6), 460–462. https://doi.org/10.1634/theoncologist.2020-0142

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free